Tricyclophosphazene derivatives, and their application as cancer

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

260239EP, C07D20306, A61K 31395

Patent

active

045956820

ABSTRACT:
The present invention especially relates to compounds of the formula: ##STR1## in which Az is an aziridinyl radical and n is an integer from 1 to 5, a process (sic) for their preparation, and their application as anti-cancer drugs.

REFERENCES:
patent: 3197464 (1965-07-01), Ottmann et al.
patent: 3299128 (1967-01-01), Allcock et al.
patent: 3311622 (1967-03-01), Joffre
patent: 4469687 (1984-09-01), Labarre et al.
De Ruiter et al., Chem. Abstracts vol. 98 (1983) p. 612 Abstract #107410g.
Prakash, Chem. Abstracts vol. 95 (1981) p. 695 Abstract #25005e.
Ristich et al., J. Econ. Entom., vol. 58(5), (1965) pp. 929-932.
Derwent Abstract of NL 8007-107 (Jul.-16-82), Abstract 67375 E/32.
Derwent Abstract of DT 2043128 (Mar.-02-72), Abstract 16886T-B.
Krishnamwthy, et al., Chemical Abstracts, vol. 93, (1980), Entry 114613c.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Tricyclophosphazene derivatives, and their application as cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tricyclophosphazene derivatives, and their application as cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclophosphazene derivatives, and their application as cancer will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2273361

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.